Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Liabilities from Discontinued Operations (2016)

Historic Liabilities from Discontinued Operations for Lisata Therapeutics (LSTA) over the last 3 years, with Q4 2016 value amounting to $10.9 million.

  • Lisata Therapeutics' Liabilities from Discontinued Operations changed N/A to $10.9 million in Q4 2016 from the same period last year, while for Dec 2016 it was $10.9 million, marking a year-over-year change of. This contributed to the annual value of $10.9 million for FY2016, which is N/A changed from last year.
  • As of Q4 2016, Lisata Therapeutics' Liabilities from Discontinued Operations stood at $10.9 million.
  • Lisata Therapeutics' 5-year Liabilities from Discontinued Operations high stood at $39.3 million for Q3 2012, and its period low was $10.9 million during Q4 2016.